Rapamycin is a clinically useful immunosuppressant that inhibits the response to interleukin-2 blocking activation of T- and B-cells and induces autophagy. Rapamycin forms a complex with cytosolic FK-binding protein 12 (FKB12) that binds to mTOR Complex1 (mTORC1), inhibiting the mammalian target of rapamycin (mTOR). It can also bind to mTORC2, leading to decreased glucose tolerance and insensitivity to insulin.
Safety Data Sheet
Kay, et al., Immunology, 72, 544 (1991).
Mita, et al., Cancer Biol. Ther., 2(4 Suppl 1), S169 (2003).
Lamming, et al., Science, 335, 1638 ( 2012).
Sarkar, et al., Cell Death and Differentiation, 16, 46 (2009).
A Flemming, et al., Nat. Chem. Biol., 11, 7 (2011).
BIOLEAF熱搜 BIOLEAF試劑盒 BIOLEAF ELISA BIOLEAF試劑 BIOLEAF品牌 BIOLEAF抗體 BIOLEAF耗材 BIOLEAF小儀器
sitemap 細(xì)胞庫(kù)查詢 危險(xiǎn)品圖標(biāo) 本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研！
滬公網(wǎng)安備 31011202007338號(hào)
